This Title All WIREs
How to cite this WIREs title:
WIREs Nanomed Nanobiotechnol
Impact Factor: 7.689

The road more traveled—common pitfalls on the way to a patent

Full article on Wiley Online Library:   HTML PDF

Can't access this content? Tell your librarian.

Abstract Drug delivery and diagnostic imaging patents represent an important subset of patents in the field of nananomedicine. In this article we review the most common rejections issued by the U.S. Patent and Trademark Office relating to these technologies. In particular, we found that the most common rejections are anticipation, obviousness and enablement. We also review the most common strategies used to overcome these rejections, which relate to “teaching away” arguments or claim amendment. WIREsNanomed Nanobiotechnol 2011 3 1–4 DOI: 10.1002/wnan.107 This article is categorized under: Toxicology and Regulatory Issues in Nanomedicine > Regulatory and Policy Issues in Nanomedicine

This WIREs title offers downloadable PowerPoint presentations of figures for non-profit, educational use, provided the content is not modified and full credit is given to the author and publication.

Download a PowerPoint presentation of all images

The trend of allowance rate at the USPTO during the past two decades.

[ Normal View | Magnified View ]

Browse by Topic

Toxicology and Regulatory Issues in Nanomedicine > Regulatory and Policy Issues in Nanomedicine

Access to this WIREs title is by subscription only.

Recommend to Your
Librarian Now!

The latest WIREs articles in your inbox

Sign Up for Article Alerts